نتائج البحث - Guillermo Rossiter

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease

    Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease حسب MW Babyatsky, Guillermo Rossiter, DK Podolsky

    منشور في 1996
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia

    Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia حسب Moisés Guelrud, Sonia Mendoza, Guillermo Rossiter, Luisa Ramirez, Jamie S. Barkin

    منشور في 1988
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease

    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease حسب Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Bin Li, Keith Usiskin, Xiaojiang Zhan, Jean‐Frédéric Colombel

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial

    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial حسب Yi‐Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hongcui Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

    Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study حسب Jeffrey S. Hyams, Dan Turner, Stanley A. Cohen, Erzsébet Szakos, Kinga Kowalska‐Duplaga, Frank M. Ruemmele, Nicholas M. Croft, Bartosz Korczowski, Promise Lawrence, Siddharth Bhatia, Harisha Kadali, Chun‐Lin Chen, Wan Sun, Maria Rosario, Senthil Kabilan, William R. Treem, Guillermo Rossiter, Richard A. Lirio

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: